3 results
Approved WMOCompleted
Part 1: To evaluate the effects of BIIB033 versus placebo on disability improvement over 72 weeks.Part 2: evaluate long-term safety profile of BIIB033 as an add-on therapy in subjects with MS.
Approved WMOCompleted
(1) To asses the influence of P-gp function at the BBB on flumazenil binding to the GABAA-receptor in pharmacoresistant patients with temporal lobe epilepsy (TLE), using PET and [11C]flumazenil as a ligand and tariquidar as P-gp blocker. (2) If we…
Approved WMOCompleted
The objective of this study is to assess the safety and effectiveness of the VENOVO * Venous Stent for the treatment of iliofemoral occlusive disease including Acute or Chronic Deep Vein Thombosis (DVT), May-Thurner Syndrome, or any combination of…